EATON CORPORATION plc
$168.67B- Market cap
- $159.57B
- Debt
- +$9.90B
- Cash
- −$803.00M
Capital structure 94% equity / 6% debt · EV / Revenue 6.14x · EV / EBITDA 31.21x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ETN stock price at discount vs ALNY $410.85 current versus $1.19K implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ALNY's multiple
Implied fair value · at ETN's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Value edge
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ETN FY 2025 (ended Dec 31, 2025) · ALNY FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 94% equity / 6% debt · EV / Revenue 6.14x · EV / EBITDA 31.21x
Capital structure 90% equity / 10% debt · EV / Revenue 10.25x · EV / EBITDA 63.81x
ETN carries the larger enterprise value at $168.67B against $38.07B; ETN trades on the lower EV / Revenue multiple (6.14x vs 10.25x); ETN on the lower EV / EBITDA (31.21x vs 63.81x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
EATON CORPORATION plc · implied price per share
Bear
$91.27
Base
$113.64
Bull
$143.83
ALNYLAM PHARMACEUTICALS, INC. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.51x
5.22x
Net debt / EBITDA
Leverage against operating earnings
1.68x
4.13x
Cash and equivalents
Liquid reserves on the balance sheet
$803.00M
$1.66B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
HONEYWELL INTERNATIONAL INC
ETN vs HON
EMERSON ELECTRIC CO
ETN vs EMR
General Electric Company
ETN vs GE
Caterpillar Inc.
ETN vs CAT
Moderna, Inc.
ETN vs MRNA
Sarepta Therapeutics, Inc.
ETN vs SRPT
VERTEX PHARMACEUTICALS INC / MA
ETN vs VRTX
BioNTech SE
ETN vs BNTX
ACADIA PHARMACEUTICALS INC
ETN vs ACAD
$9.90B
$4.12B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.